Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
  2. News
  3. novel bispecific fusion protein
Show results for
Products
Companies
News
Refine by
Date

Novel Bispecific Fusion Protein Articles & Analysis

1 news found
Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to nemvaleukin alfa (nemvaleukin), the company's novel, investigational, engineered interleukin-2 (IL-2) variant immunotherapy, at the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium, taking place Jan. 20-22, 2022. The poster highlights clinical data related to advanced GI cancers ...

ByAlkermes

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you